Effect of Anthocyanins Extracted From Purple Potatoes on Healthy Study Subjects' Postprandial Glycemia and Insulinemia
- Conditions
- Postprandial Glycemia
- Interventions
- Other: Dietary
- Registration Number
- NCT02940080
- Lead Sponsor
- University of Turku
- Brief Summary
A randomized, single-blind cross-over clinical nutrition trial will be conducted. The effects of yellow-fleshed potatoes and yellow-fleshed potatoes supplemented with anthocyanins extracted from purple-fleshed potatoes on healthy men's postprandial glycemia and insulinemia will be compared. Additionally, the postprandial metabolism and metabolites, and the appearance and metabolism of the flavonoids and their metabolites is studied in plasma, urine and feces.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 18
- Age 18-45
- Male
- No regular medication
- No participation in a drug trial or blood donation within 2 months
- Non-smoker
- Signs informed consent
- Body mass index 18.5-27 kg/m2
- Fasting plasma cholesterol < 5.5 mmol/l
- Fasting plasma triacylglycerols < 2.6 mmol/l
- Fasting plasma glucose 4-6 mmol/l
- blood pressure <140/80 mmHg
- hemoglobin>130 g/l
- Fasting plasma alanine amino transferase (ALAT) <60 U/l (normal liver function)
- Fasting plasma thyroid-stimulating hormone (TSH) 0.4 - 4.5 mU/l (normal thyroid function)
- Fasting plasma creatinine <118 µmol/l (normal kidney function)
- Regular smoking
- Alcohol abuse
- Regular medication
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Yellow potato Dietary 350 g of steam-cooked mashed potatoes in water Anthocyanins and yellow potato Dietary 168 mg of anthocyanins extracted from purple-fleshed potatoes added to 350 g of steam-cooked mashed potatoes in water
- Primary Outcome Measures
Name Time Method Plasma insulin concentration 0min, 20min, 40min, 60min, 90min, 120min, 180min, 240min Plasma glucose concentration 0min, 20min, 40min, 60min, 90min, 120min, 180min, 240min
- Secondary Outcome Measures
Name Time Method Concentrations and quality of metabolites and flavonoid color compounds and their metabolites in plasma (NMR and (U)HPLC-MS/MS measurements) 0min, 20min, 40min, 60min, 90min, 120min, 180min, 240min Concentrations and quality of metabolites and flavonoid color compounds and their metabolites in urine (NMR and (U)HPLC-MS/MS measurements) Before meal, and 0-4h, 4-8h, 8-16h, 16-24 h Concentrations and quality of metabolites and flavonoid color compounds and their metabolites in feces (NMR and (U)HPLC-MS/MS measurements) before and after meal Area under the glucose concentration curve (AUC) 0min, 20min, 40min, 60min, 90min, 120min, 180min, 240min Area under the insulin concentration curve (AUC) 0min, 20min, 40min, 60min, 90min, 120min, 180min, 240min
Trial Locations
- Locations (1)
Department of Biochemistry, University of Turku
🇫🇮Turku, Finland